Genoray Co., Ltd. (KOSDAQ: 122310)

Market Cap	78.81B
Revenue (ttm)	108.42B
Net Income (ttm)	10.24B
Shares Out	13.40M
EPS (ttm)	751.40
PE Ratio	7.83
Forward PE	n/a
Dividend	160.00 (2.72%)
Ex-Dividend Date	Apr 2, 2024

Volume	12,410
Open	5,910.00
Previous Close	5,910.00
Day's Range	5,860.00 - 5,940.00
52-Week Range	5,500.00 - 8,590.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Genoray

Genoray Co., Ltd. engages in the research, development, manufacture, and sale of medical and dental x-ray devices in South Korea. It offers C-ARM and mammography medical x-ray devices; and 2D, 3D, ENT, and IOS/IOX dental x-ray devices, as well as related maintenance and repair services. The company also exports its products to approximately 80 countries worldwide. Genoray Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2001
• Employees: 329
• Stock Exchange: KOSDAQ
• Ticker Symbol: 122310

Financial Performance

In 2023, Genoray's revenue was 97.90 billion, an increase of 18.51% compared to the previous year's 82.60 billion. Earnings were 12.49 billion, a decrease of -10.17%.